Detalhe da pesquisa
1.
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse.
Blood
; 140(17): 1907-1916, 2022 10 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35789260
2.
Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience.
Hematol Oncol
; 42(3): e3273, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38661120
3.
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Haematologica
; 108(4): 1083-1091, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36384247
4.
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Hematol Oncol
; 41(1): 78-87, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36177902
5.
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network).
Ann Hematol
; 102(4): 841-849, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36735074
6.
Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone.
Eur J Haematol
; 111(2): 247-253, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37161912
7.
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the "RTL" (Regional Tuscan Lymphoma network).
Eur J Haematol
; 108(5): 383-390, 2022 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35051301
8.
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study.
Blood
; 134(10): 798-801, 2019 09 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31292118
9.
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab.
Br J Haematol
; 184(2): 223-231, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30203425
10.
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
Oncologist
; 24(8): e720-e729, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30552159
11.
Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia.
Blood
; 130(18): 2006-2017, 2017 11 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28931525
12.
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).
Oncologist
; 23(9): 1033-1038, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29674440
13.
Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review.
Ann Hematol
; 97(5): 821-829, 2018 May.
Artigo
Inglês
| MEDLINE | ID: mdl-29340761
14.
New perspectives for patients with primary cutaneous diffuse large B-cell lymphoma, leg-type.
Chemotherapy
; 2023 Dec 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38071958
15.
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment.
Hematol Oncol
; 35(1): 69-78, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26251194
16.
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the "RTL" (Regional TUSCAN Lymphoma Network)-Authors' reply to Morris and colleagues.
Eur J Haematol
; 109(5): 595-596, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35848909
17.
Direct-acting antivirals in hepatitis C virus-positive mantle cell lymphomas.
Hematol Oncol
; 39(2): 263-266, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33150988
18.
Long-term remission in a case of plasmablastic lymphoma treated with COMP (cyclophosphamide, liposomal doxorubicin, vincristine, prednisone) and bortezomib.
Eur J Haematol
; 96(6): 650-654, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26715026
19.
The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells.
Blood
; 119(9): 2106-9, 2012 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22234701
20.
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients.
Haematologica
; 104(1): e25-e28, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29954940